Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Real Life, Prospective, Observational, Single-Center Study

Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Real Life, Prospective, Observational, Single-Center Study

Evidence-based, standard antibiotic therapy for ventilator-associated pneumonia (VAP) caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) is a relevant unmet clinical need in the intensive care unit (ICU). We aimed to evaluate the effectiveness of first-line therapy with...

Full description

Bibliographic Details
Main Authors: Lidia Dalfino, Monica Stufano, Davide Fiore Bavaro, Lucia Diella, Alessandra Belati, Stefania Stolfa, Federica Romanelli, Luigi Ronga, Rosa Di Mussi, Francesco Murgolo, Daniela Loconsole, Maria Chironna, Adriana Mosca, Maria Teresa Montagna, Annalisa Saracino, Salvatore Grasso
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Antibiotics
Subjects:
ventilator-associated pneumonia
carbapenem-resistant <i>Acinetobacter baumannii</i>
cefiderocol
colistin
nosocomial pneumonia
critically ill patients
Online Access:https://www.mdpi.com/2079-6382/12/6/1048

Internet

https://www.mdpi.com/2079-6382/12/6/1048

Similar Items